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doi:10.1016/j.jfma.2011.09.021Background/Purpose: This study aims at evaluating the relationship between visual impair-
ment and health-related quality of life (QoL) by identifying factors that affect the EQ-5D index
score and Visual Functioning Questionnaire (VFQ) global score, and determining whether the
VFQ-25 scores and the European Quality of Life-5 Dimensions (EQ-5D) scores are correlated.
Methods: This cross-sectional study comprised 318 patients aged 40 years or more presenting
with best corrected visual acuity (BCVA) of 20/40 or worse in the better eye.Patients received
comprehensive ophthalmologic examinations, and were administered the National Eye Insti-
tute VFQ-25 and the EQ-5D instruments. A higher VFQ-25 score indicates a better QoL and,
after conversion of the EQ-5D scores to an index score, a higher EQ-5D index score indicates
a better QoL.
Results: On multivariate analysis of the EQ-5D index scores, women and those with arthritis
were found to have significantly worse QoL, and the EQ-5D index score was increased by every
unit increase in BCVA or mean deviation. Multivariate analysis of the VFQ-25 scores revealed
that a history of heart disease, arthritis, and eye diseases, such as age-related macular degen-
eration or diabetic retinopathy, had significant negative effects on patients’ QoL, and VFQ-25
global score was decreased by every unit increase in logMAR. According to this analysis,
patients’ QoL was improved by each unit increase in BCVA or mean deviation. The correlation
between the two questionnaires was only weak to moderate.
Conclusion: Visual impairment was associated with lower QoL, as assessed by either question-
naire in Taiwanese patients.
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Visual impairment lessens quality of life 573Introduction MethodsObjective assessments of visual function address neither
the effect of visual impairment on quality of life (QoL) nor
the burden of disease. Total medical expenditures for
blindness and visual impairment are USD $4000 per person
per year, and this number does not include costs associ-
ated with lost productivity, anxiety, and untold distress.1,2
Assessment of health-related QoL is thought to provide
a more complete understanding of disease burden than
does assessment of somatic injury alone because it
includes the patient’s perspective.3,4 With visual impair-
ment, QoL may be affected by a reduced ability to
conduct activities of daily living or interact socially.5 For
example, patients with glaucoma report reduced QoL
because they trip over items in their peripheral vision,
cannot adapt to darkness, or cannot distinguish items
because of glare.6 In addition, visual impairment is asso-
ciated with depression, frustration, and anxiety, not only
because of the impairment, but also because of the
accompanying worry that the condition may worsen, the
anticipated pain of treatment, or the difficulty in adjust-
ing to reduced activity.7e9
Assessment of QoL associated with visual impairment
can help policy makers allocate health-care resources
across diseases and populations.10 One study showed that
bilateral mild visual impairment was comparable to
unilateral moderate or severe visual impairment, indi-
cating that having at least one good eye was enough to
raise QoL.5 A study by Knudtson et al,3 which examined the
associations between measures of QoL and functional
activities in persons with and without age-related eye
diseases, found that decreased visual function, irre-
spective of the pathologic reason for the decrease, is
associated with diminished QoL and functional activities of
living. In a study conducted in India, decreased QoL was
associated with visual impairment due to cataract and
retinal disease; however, patients with glaucoma or
corneal disease experienced lower QoL regardless of their
visual impairment, possibly because they were more likely
to be bilaterally blind.11
The Visual Functioning Questionnaire (VFQ)-25 and the
European Quality of Life-5 Dimensions (EQ-5D) are vali-
dated questionnaires that have been used to assess the
QoL. The VFQ-25 is a 25-item version of the 51-item
National Eye Institute Visual Function Questionnaire (NEI-
VFQ),12 which specifically addresses visual function. The
EQ-5D is a standardized measure of health outcome
developed to allow comparisons across populations.13,14
Evaluation of QoL is clinically important because it can
guide development of targeted interventions to improve
QoL, even when improving vision is not feasible. However,
whether to use a questionnaire that focuses on visual
function or one that assesses overall QoL is still a matter of
debate.
To determine how visual function affects the scores of
these questionnaires among patients with a variety of
ocular disorders, we explored whether factors that affect
the EQ-5D index score and VFQ global score could be
identified, and whether there was a correlation between
the VFQ-25 scores and the EQ-5D scores.Participants
Patients presenting for follow-up examinations at a regional
hospital in Taipei between January 1, 2008 and May 31,
2008 were eligible for the study if they aged 40 years or
older, were visually impaired [defined as best corrected
visual acuity (BCVA) of 20/40 or worse in the better eye],
spoke Chinese, had no impairments of cognition or hearing,
could walk independently without the assistance of
a device or other people, and had no history of laser or
incisional eye surgery in the preceding 3 months. In total,
318 eligible patients were enrolled in the study, of whom 87
(27.3%) had cataracts, 69 (21.7%) had glaucoma, 51 (16.0%)
had age-related macular degeneration (ARMD), 65 had
(20.4%) diabetic retinopathy (DR), and 46 (14.5%) had
uncorrected refractive error (URE) (defined as mild hyper-
opia or myopia with more than two lines between pre-
senting and BCVA, and no pathologic change of the retina).
All eligible patients received comprehensive ophthal-
mologic examinations, including slit-lamp biomicroscopy
and automatic perimeter examination (Auto Kerato-
Refractometer; Topcon Corporation, Tokyo, Japan). Visual
acuity was tested with the Snellen E chart and corrected
with prescription lenses, as needed. Pneumotonometry was
used to measure intraocular pressure (IOP). Ocular fundus
examination was performed by nonmydriatic digital retinal
and optic disc photography. Visual field (VF) examination
was performed with the FDT-perimeter (Zeiss Humphrey
Systems, Dublin, CA, USA) using frequency-doubling tech-
nology (FDT).15 Although FDT was originally designed to
detect early glaucomatous loss, other ocular and neuro-
logical disorders that cause VF loss can also be detected
with it.15 Mean deviation (MD) and pattern standard devi-
ation (PSD) were recorded. MD represents the deviation in
average sensitivity from that of a normal healthy person of
the same age (normative data). It is an indication of overall
VF sensitivity, and can have either a negative or a positive
value, depending on the relationship of that individual’s
general contrast sensitivity to the age group average. PSD
indicates how each test location, on average, deviates from
the age-adjusted normative database after adjustment for
any general depression or supersensitivity. It represents
how evenly the field loss is spread across the VF, thus
indicating localized loss. PSD can only be equal to or
greater than zero, and higher PSD values represent more
irregularities in the VF. Contrast sensitivity was not
evaluated.
After complete ophthalmologic examinations, patients
were divided into five groups according to whether they had
cataracts,glaucoma, ARMD, DR, or URE. These categories
were chosen because they represent the most common
causes of vision impairment in adults worldwide16; the
patients with URE served as the reference group. Patients
with more than one eye disease were included in the group
that represented their most serious visual problem. In brief,
among people with a pinhole visual acuity of 20/40 or
better in either eye, the principal reason for visual
impairment was refractive error, and further information
on the cause of visual impairment was sought only for the
Table 1 Summary of patient characteristics.
(n Z 318)
Demographics
Age (y) 74.0 (66.0, 79.0)
574 J.-C. Lin, J.-H. Yuremaining people who had no pinhole visual acuity or whose
pinhole visual acuity did not improve beyond 20/40. If
cataract and a posterior-segment lesion of the optic nerve
or retina coexisted, and removal of cataract would not
restore vision, the cause of blindness was considered to be
the posterior-segment lesion. If dense cataract that pre-
vented any view of the posterior segment was present, and
if there were no signs suggestive of any other cause of
visual loss, the cause of blindness was considered to be
cataract. This was determined by the same ophthalmologist
for all patients, i.e., the same ophthalmologist was asked
to rank any conditions noted in order of their contribution
to the cause of visual loss.
A single interviewer administered both QoL instruments,
the Chinese (Taiwanese) version of the VFQ-2512 and the
EQ-5D (Chinese version),14 to each patient face to face.
These instruments have previously been used to determine
vision-related QoL under the conditions studied.10 This
research followed the tenets of the Declaration of Helsinki,
and both Institutional Review Board approval and informed
consent from all patients prior to study initiation were
obtained.Sex Male 153 (48.1%)
Female 165 (51.9%)
Education
level
6 y 195 (62.3%)
7e12 y 87 (27.8%)
>12 y 31 (9.9%)
Employment Employed 30 (9.4%)
Unemployed 288 (90.6%)
Religion 244 (76.7%)
Monthly income 10,000 NTD 219 (68.9%)
Abstained or presently smokers 93 (29.2%)
Disease history
Diabetes 101 (38.1%)
Hypertension 134 (51.7%)
Heart disease 65 (25.1%)
Arthritis 37 (14.3%)
Other disease 27 (10.4%)
Eye disease Cataract 87 (27.4%)
Glaucoma 69 (21.7%)
ARMD 51 (16.0%)
Diabetic retinopathy 65 (20.4%)
Uncorrected refractive
errors
46 (14.5%)
Measurement of visual ability
LogMAR of better eye 0.4 (0.3, 0.5)
LogMAR of worse eye 0.7 (0.5, 1.1)
BCVA of better eye 0.4 (0.3, 0.5)
BCVA of worse eye 0.2 (0.1, 0.3)Instruments
The VFQ-25 generates the following vision-targeted
subscales: global vision rating to provide an overall
assessment of vision; difficulty with activities dependent on
near vision; difficulty with activities dependent on distance
vision; limitations in social functioning and activities,
dependency on others, and mental health symptoms due to
vision; driving difficulties; limitations with peripheral and
color vision; and ocular pain.12 Scores for each subscale
(1e5 per item) are converted to a scale of 0e100. After
missing data have been deleted, the subscales are averaged
together to provide a composite score, with 100 and
0 signifying, respectively, the best and the worst possible
health state. A validated Chinese language (Taiwanese)
version is available.17
In the EQ-5D, participants are asked to rate their level of
function by answering specific questions regarding five
domains (mobility, self-care, usual activities, pain/
discomfort, and anxiety/depression). Patients choose from
one of three possible answers for each question, with
a score of 1 being the best and 3 being the worst. For
analysis, the EQ-5D score is mathematically converted to an
EQ-5D index, and a higher EQ-5D index score indicates
a better level of function or QoL. The Chinese version has
been validated in a Taiwanese population.18IOP of better eye (mmHg) 11.6 (9.0, 13.8)
IOP of worse eye (mmHg) 11.5 (9.3, 14.3)
MD of better eye (dB) 5.4 (10.1, 1.8)
MD of worse eye (dB) 7.6 (15.0, 3.5)
PSD of better eye 5.5 (4.3, 7.8)
PSD of worse eye 5.4 (4.2, 7.4)
ARMD Z age-related macular degeneration; BCVA Z best cor-
rected visual acuity; IOP Z intraocular pressure; MD Z mean
deviation; NTD Z new Taiwan dollars; PSD Z pattern standard
deviation.Main outcome measures
Patient demographic data (e.g., age, sex, marital status,
years of education, employment, any religious affiliation,
income, smoking, and comorbidities) and clinical charac-
teristics were recorded, and the instruments were analyzed
to assess QoL. The relationships among overall and subscale
QoL to visual function score with presenting BCVA in the
better eye, specific eye diseases, and demographic vari-
ables were assessed.Statistical analysis
All continuous variables were expressed as median with
interquartile ranges because of skewed distributions.
Number and percent were computed for categorical vari-
ables. Spearman rank correlation (r) was used to quantify
the correlation between the EQ-5D scores and VFQ-25
scores, and correlations were defined as follows: very
weak (r  0.2), weak (0.2 < r  0.4), moderate
(0.4 < r  0.6), strong (0.6 < r  0.8), and very strong
(r > 0.8). Simple and multiple linear regression models for
the VFQ-25 global score and the EQ-5D index score were
presented by the weight coefficients (b) with 95% confi-
dence interval (CI). The variables with significant
Visual impairment lessens quality of life 575coefficients in simple linear regression models were
selected for incorporation into the multiple linear regres-
sion model by the forward conditional method. A two-
sided p value <0.05 was considered statistically signifi-
cant. All statistical analyses were performed with SPSS
statistical software, version 15.0 (SPSS Inc., Chicago, IL,
USA).
Results
Patient characteristics
A total of 318 patients, 153 (48.1%) men and 165 (51.9%)
women, with a median age of 74.0 years, were enrolled in
the study (Table 1). Approximately 90% of the patients were
unemployed, and 68.9% had a monthly income lower than
10,000 new Taiwan dollars (NTD). About half of the patients
had a history of hypertension, 38.1% had diabetes, and
14.3% had arthritis.Table 2 Summary of EQ-5D and VFQ-25 measurements.
EQ-5D results
Mobility I have no problems in walking a
I have some problems in walkin
I am confined to bed
Self-care I have no problems with self-ca
I have some problems washing
I am unable to wash or dress m
Usual activities I have no problems with perform
I have some problems with perf
I am unable to perform my usua
Pain/discomfort I have no pain or discomfort
I have moderate pain or discom
I have extreme pain or discomf
Anxiety/depression I am not anxious or depressed
I am moderately anxious or dep
I am extremely anxious or depr
EQ-5D index score
VFQ-25 results
General health
General vision
Ocular pain
Near activities
Distant activities
Social function
Mental health
Role limitations
Dependency
Driving
Color vision
Peripheral vision
Global score
Continuous variables were presented as median with interquartile rang
were presented by count with percentage.
A higher score in the five EQ-5D domains means poor health and qualit
index score means better health and quality of life.
EQ-5D Z European Quality of Life-5 Dimensions; VFQ-25 Z Visual FuVFQ-25 and EQ-5D scores
A summary of the VFQ-25 and EQ-5D scores is given in Table
2. In the EQ-5D, about 40% of the patients reported feeling
moderately or extremely anxious or depressed, and 43.7%
reported moderate or severe pain. Most patients could walk
without difficulty (76.4%), take care of themselves (89.6%),
and manage activities of daily living without assistance
(79.9%).
Correlation of the EQ-5D and VFQ-25 scores
According to the results revealed by Spearman’s correlation
analysis, 12 items of the VFQ-25 displayed negative and
weak-to-moderate correlations with the five items included
in the EQ-5D (Table 3), whereas positive correlation with
the EQ-5D index score.
Because some authors have suggested that the VFQ-25
scale involves at most four independent constructs(n Z 318)
round 243 (76.4%)
g around 75 (23.6%)
0 (0.0%)
re 285 (89.6%)
or dressing myself 29 (9.1%)
yself 4 (1.3%)
ing my usual activities 254 (79.9%)
orming my usual activities 51 (16.0%)
l activities 13 (4.1%)
179 (56.3%)
fort 129 (40.6%)
ort 10 (3.1%)
193 (60.7%)
ressed 107 (33.6%)
essed 18 (5.7%)
0.85 (0.73, 1.00)
25.0 (25.0, 50.0)
60.0 (40.0, 60.0)
75.0 (62.5, 87.5)
75.0 (58.3, 100.0)
83.3 (62.5, 100.0)
100.0 (75.0, 100.0)
68.8 (43.8, 87.5)
62.5 (37.5, 100.0)
75.0 (50.0, 100.0)
83.3 (45.8, 100.0)
100.0 (100.0, 100.0)
100.0 (75.0, 100.0)
77.4 (60.4, 89.0)
e (25th percentile and 75th percentile), and categorical variables
y of life; however, after conversion to an “index,” a higher EQ-5D
nctioning Questionnaire-25.
Table 3 Correlations between visual function and quality of life (Spearman’s correlation coefficients of VFQ-25 vs. EQ-5D).
Mobility Self-care Usual
activities
Pain/
discomfort
Anxiety
depression
EQ-5D index
score
General health 0.393* 0.294* 0.406* 0.358* 0.351* 0.466*
General vision 0.279* 0.243* 0.309* 0.107 0.086 0.204*
Ocular pain 0.259* 0.283* 0.268* 0.378* 0.271* 0.405*
Near activities 0.410* 0.327* 0.433* 0.253* 0.246* 0.383*
Distant activities 0.483* 0.389* 0.494* 0.325* 0.196* 0.432*
Social function 0.511* 0.440* 0.485* 0.275* 0.243* 0.432*
Mental health 0.389* 0.347* 0.377* 0.2* 0.273* 0.341*
Role difficulties 0.439* 0.323* 0.407* 0.28 0.296* 0.426*
Dependency 0.488* 0.386* 0.435* 0.18* 0.238* 0.346*
Color vision 0.407* 0.400* 0.415* 0.237* 0.241* 0.376*
Peripheral vision 0.481* 0.429* 0.497* 0.288* 0.216* 0.412*
Global score 0.48* 0.390* 0.467* 0.301* 0.271* 0.442*
Mood state 0.483* 0.382* 0.446* 0.237* 0.280* 0.401*
Functional ability 0.485* 0.396* 0.480* 0.249* 0.198* 0.380*
* Indicates significantly related to items of EQ-5D and EQ-5D index score, p < 0.05.
A higher score in the five EQ-5D domains means poor health and quality of life, but after conversion to an “index”, a higher EQ-5D index
score Z better health and quality of life.
EQ-5D Z European Quality of Life-5 Dimensions; VFQ-25 Z Visual Functioning Questionnaire-25.
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health),19,20 we also performed an analysis according to
these constructs (Table 3). The results were similar to those
for the other VFQ-25 subscales, with moderate negative
correlations between the four constructs and the items in
the EQ-5D scale, but moderate positive relationships with
the EQ-5D index score.
Global VFQ-25 score
In a univariate analysis, patients with a monthly income of
less than 10,000 NTD or a history of hypertension, heart
disease, or arthritis had significantly worse VFQ-25 global
scores (Table 4). Patients with glaucoma, ARMD, and DR had
significantly worse global VFQ-25 scores than those with
URE. The global scores of VFQ-25 were improved with every
unit increase in BCVA and MD, and every unit decrease in
logMAR.
After controlling for all other variables, patients with
heart disease had a significantly worse VFQ-25 global score
than those without heart disease, patients with arthritis
had a significantly worse global score than those without
arthritis, and patients with ARMD and DR had significantly
worse global scores than those with URE. Patient QoL
(according to the VQF-25 global score) also improved with
better logMAR and MD (Table 5).
EQ-5D index score
In a univariate analysis, patients with a better QoL (higher
EQ-5D index score) were more likely to be men. In addition,
patients with a monthly income less than 10,000 NTD were
more likely to have a worse QoL. The EQ-5D index score was
increased with every unit increase in BCVA, IOP, and MD.
Patients with a history of heart disease or arthritis had
worse QoL (lower EQ-5D index score) (Table 4). Multivariateanalysis showed similar results. After controlling for all
other variables, a better QoL was seen in men, and again
the EQ-5D index score was increased with every unit
increase in BCVA and MD, and patients with a history of
arthritis had worse QoL (Table 5).Discussion
In this study, we compared the results of two question-
naires that were used to evaluate health-related QoL (one
focused on visual function and the other assessed overall
QoL) among a population of older Taiwanese adults with
a range of visual impairments. In general, we found that the
correlation between the VFQ-25 and the EQ-5D was weak to
moderate. Multivariate analysis of the EQ-5D index scores
showed that women and patients with arthritis had signifi-
cantly poorer QoL. With respect to visual ability, only the
BCVA and MD of the better eye had a significant effect on
QoL. Multivariate analysis of the VFQ-25 global scores
revealed that a history of heart disease, arthritis, and eye
diseases such as ARMD or DR significantly affected patient
QoL. Among the measures of visual ability, logMAR and MD
of the better eye affected QoL, as assessed by the VFQ-25
questionnaire.
Our observation that patients with DR and ARMD had
very poor QoL, as determined by univariate analysis of the
VFQ-25 global scores, may be explained by the fact that
these patients also tended to have the poorest scores for
visual functions (BCVA and MD). Another possible reason is
that these patients would be expected to have more
prevalent and more severe comorbidities, which have been
shown to have a significant effect on QoL, as determined by
the VFQ-25.2,20
After multivariate analysis of our data, the BCVA
remained significantly correlated with QoL in addition to
the presence of these two serious ophthalmic diseases. This
Table 4 Univariate linear regression models for EQ-5D index score and VFQ-25 global index score.
EQ-5D index score VFQ-25 global score
b (95% CI) p b (95% CI) p
Demographics
Age (y) 0.002 (0.004, 0.001) 0.231 0.012 (0.218, 0.243) 0.915
Sex
Male 0.110 (0.055, 0.166) <0.001* 0.235 (4.529, 4.999) 0.923
Female d d
Education level
6 y 0.076 (0.172, 0.021) 0.126 0.280 (8.465, 7.906) 0.946
7e12 y 0.013 (0.091, 0.118) 0.802 3.572 (5.284, 12.427) 0.428
>12 y d d
Employment
Employed 0.056 (0.040, 0.153) 0.253 0.271 (7.845, 8.387) 0.948
Unemployed d d
Religion 0.061 (0.127, 0.006) 0.073 0.728 (4.886, 6.341) 0.799
Monthly income 10,000 NTD 0.089 (0.149, 0.029) 0.004* 8.103 (13.147, 3.058) 0.002*
Abstained or presently smokers 0.005 (0.057, 0.067) 0.875 4.793 (9.982, 0.395) 0.070
Disease history
Diabetes 0.029 (0.094, 0.035) 0.371 4.658 (10.068, 0.752) 0.091
Hypertension 0.043 (0.106, 0.020) 0.182 5.673 (11.004, 0.343) 0.037*
Heart disease 0.096 (0.168, 0.023) 0.010* 10.422 (16.484, 4.360) <0.001*
Arthritis 0.189 (0.277, 0.101) <0.001* 9.018 (16.614, 1.422) 0.020*
Other disease 0.097 (0.200, 0.006) 0.066 6.290 (15.047, 2.466) 0.158
Eye disease
Cataract 0.008 (0.099, 0.084) 0.871 5.950 (13.302, 1.403) 0.112
Glaucoma 0.035 (0.131, 0.061) 0.471 11.679 (19.356, 4.002) 0.003*
ARMD 0.054 (0.156, 0.048) 0.301 17.984 (26.185, 9.783) <0.001*
Diabetic retinopathy 0.077 (0.174, 0.020) 0.119 19.116 (26.887, 11.345) <0.001*
Uncorrected refractive errors d d
Measurement of visual ability
BCVA of better eye 0.425 (0.243, 0.607) <0.001* 78.310 (65.106, 91.515) <0.001*
BCVA of worse eye 0.197 (0.013, 0.381) 0.035* 57.656 (43.518, 71.795) <0.001*
LogMAR of better eye 0.206 (0.290, 0.122) <0.001* 38.626 (44.561, 32.691) <0.001*
LogMAR of worse eye 0.029 (0.070, 0.013) 0.178 12.481 (15.694, 9.269) <0.001*
IOP of better eye 0.0031 (0.0050, 0.0112) 0.454 0.138 (0.820, 0.544) 0.691
IOP of worse eye 0.0071 (0.0008, 0.0135) 0.027* 0.046 (0.488, 0.580) 0.866
MD of better eye 0.0069 (0.0027, 0.0112) 0.001* 1.270 (0.926, 1.614) <0.001*
MD of worse eye 0.0068 (0.0028, 0.0107) <0.001* 1.354 (1.037, 1.671) <0.001*
PSD of better eye 0.0007 (0.0093, 0.0080) 0.882 0.340 (1.089, 0.410) 0.373
PSD of worse eye 0.0005 (0.0113, 0.0103) 0.930 0.952 (0.031, 1.872) 0.043*
A higher EQ-5D index score and a higher VFQ-25 global score mean better health and quality of life.
* Significantly correlated with outcome, p < 0.05.
ARMD Z age-related macular degeneration; BCVA Z best corrected visual acuity; EQ-5D Z European Quality of Life-5 Dimensions;
IOP Z intraocular pressure; MD Z mean deviation; NTD Z new Taiwan dollars; PSD Z pattern standard deviation; VFQ-25 Z Visual
Functioning Questionnaire-25.
Visual impairment lessens quality of life 577agrees with the results of several recent studies on QoL.
Knudtson et al3 demonstrated that although many measures
of QoL were related to age-related eye disease, few
remained significant after adjustment for vision and other
comorbidities. Matza et al21 showed that patients with DR
who were tracked over time and experienced progressive
visual impairment scored more poorly on nearly all VFQ-25
subscales than patients with DR whose BCVA did not
change. Clearly, visual function is an important factor that
affects QoL.Finally, we found that the correlation between the two
questionnaires was only weak to moderate. This is consis-
tent with a previous analysis of the best algorithm to
predict EQ-5D scores from the VFQ-25 in patients with
ARMD, which recommended use of only the EQ-5D general
health scores and the composite score in predicting the
VFQ-25.22 However, patient population must be considered
when interpreting the relatively poor correlation between
the two instruments. In our patient population, most
patients could walk without difficulty (76.4%), take care of
Table 5 Multivariate linear regression models for EQ-5D index score and VFQ-25 global index score.
EQ-5D index score VFQ-25 global score
b (95% CI) p b (95% CI) p
Sex
Male 0.067 (0.010, 0.124) 0.020*
Female d
Heart disease 8.580 (13.724, 3.436) 0.001*
Arthritis 0.136 (0.216, 0.055) 0.001* 7.924 (14.062, 1.786) 0.012*
Eye disease
Cataract 3.706 (11.850, 4.438) 0.371
Glaucoma 7.582 (15.892, 0.728) 0.074
ARMD 11.262 (20.515, 2.009) 0.017*
Diabetic retinopathy 11.376 (19.869, 2.882) 0.009*
Uncorrected refractive errors d
Measurement for visual ability
BCVA of better eye 0.318 (0.113, 0.523) 0.003*
LogMAR of better eye 25.206 (33.586, 16.826) <0.001*
MD of better eye 0.0052 (0.0004, 0.0101) 0.035* 0.683 (0.289, 1.077) <0.001*
Only the measurements for visual ability in the better eye were included to avoid collinearity in the multivariate model.
“d” indicates the reference category.
* Significantly correlated with outcome, p < 0.05.
ARMD Z age-related macular degeneration; BCVA Z best corrected visual acuity; EQ-5D Z European Quality of Life-5 Dimensions;
MD Z mean deviation; VFQ-25 Z Visual Functioning Questionnaire-25.
578 J.-C. Lin, J.-H. Yuthemselves (89.6%), and manage activities of daily living
without assistance (79.9%); hence, their EQ-5D scores
would indicate a good QoL, as the EQ-5D mainly assesses
general health and the ability to perform daily activities. In
contrast, the VFQ-25 mainly assesses vision-dependent
QoL; therefore, those with poor eyesight would be ex-
pected to have poorer scores. If patients were severely
visually impaired such that their activities of daily living
were significantly affected, we would expect the correla-
tion between the two instruments to be better.
Some interesting and unexpected results emerged from
the analysis of the data in this study. The EQ-5D index
score, which is a more general instrument, was, as ex-
pected, correlated with a variety of factors that were
unrelated to vision (e.g., level of education, history of
arthritis, and history of other diseases). Surprisingly, the
global VFQ-25 score was correlated with a history of heart
disease, whereas the EQ-5D score was not, even though the
VFQ-25 is designed to measure the effects of vision on QoL
more specifically. Additional evaluations in a larger pop-
ulation will be needed to confirm whether or not the results
we observed reflect a link between diseases of the circu-
latory system and vision-related QoL. This is an important
issue as some interesting relationships between retinal
vascular patterns and certain heart diseases are beginning
to emerge.23,24 A case has been reported in which branch
retinal artery occlusion was caused by calcific embolization
secondary to calcific aortic valvulopathy,25 and anti-
coagulation has been hypothesized to be linked to intra-
ocular hemorrhage in ARMD.26
A general limitation of our study results from the ceiling
effect, a limited ability to discriminate among those who
are in relatively good health, which also limits the ability of
the EQ-5D to make distinctions for those with relatively less
visual impairment.13Conclusions
In conclusion, visual ability has a significant impact on QoL.
This was true for the scores obtained with an instrument
that focused on visual function (VFQ-25) and also for the
scores produced by an instrument that assessed issues more
related to overall health (EQ-5D). MD had a significant
independent effect on the scores from both questionnaires,
whereas IOP affected the EQ-5D score independently and
BCVA affected the VFQ-25. The correlation between the
two questionnaires was only weak to moderate; however,
this may be related to the general high functioning of the
population studied.
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